ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 279

Comparison of Carotid Ultrasound and Coronary Artery Calcium Score in Cardiovascular Risk Stratification of Patients with Inflammatory Rheumatic Diseases

Keith Colaco1, Elsie Nguyen 2, Shadi Akhtari 3, Paula Harvey 3 and Lihi Eder 4, 1University of Toronto, Women's College Hospital, University Health Network, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Women's College Hospital, Toronto, ON, Canada, 4Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cardiovascular disease, Imaging, risk assessment and inflammatory arthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Imaging Of Rheumatic Diseases Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The value of non-invasive vascular imaging for cardiovascular (CV) risk stratification of patients with inflammatory rheumatic diseases is unclear. Measures of atherosclerosis including coronary artery calcification score (CACS) on computerized tomography (CT) scan and both total plaque area (TPA) and carotid intima-media thickness (cIMT) by carotid ultrasound (US) have been reported to improve risk stratification beyond the Framingham Risk Score (FRS). We determined the ability of CACS and US to correctly identify high CV risk patients with inflammatory rheumatic diseases.

Methods: In this cross-sectional study, patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA) and rheumatoid arthritis (RA), who had no history of CV disease, underwent assessment of CV risk factors from July 2017 to March 2019 in a Cardio-Rheumatology clinic. CACS, cIMT and TPA were measured. The correlation between CACS and cIMT, between CACS and TPA, and between cIMT and TPA was assessed by Pearson correlation coefficient. Based on the FRS, patients were classified into low (< 10%), intermediate (10-20%) and high risk categories ( >20%). Risk categories for US were defined as low (zero plaque and cIMT< 0.9mm), intermediate (unilateral plaque) and high risk (cIMT >0.9mm and/or bilateral plaques). CACS risk categories were defined as low (CACS=0), intermediate (0-100) and high risk ( >100). The weighted Kappa statistic was used to assess agreement between score categories.

Results: 139 patients with RA (49.6%), PsA (37.4%) and AS (12.9%) were assessed (mean age 61.2 ± 10.9 years, 66.9% female) (Table 1). CACS correlated moderately with TPA (r=0.42, p< 0.0001), while there was very weak correlation between CACS and cIMT (r=0.08), and between TPA and cIMT (r=0.14). 29.7% and 16.2% of patients classified into the low and intermediate risk categories based on the FRS had significant atherosclerosis in the carotid (TPA >0) and coronary arteries (CACS >100), respectively (Table 2). 50% of patients in the FRS intermediate risk category were reclassified into an US low risk group, while 35.7% of patients in the FRS high risk category were reclassified into an US low risk group. Importantly, when comparing US and CACS risk categories, 54% of patients in the intermediate CACS risk category were reclassified into a low risk US group (Table 3). There was generally good agreement between the FRS and CACS risk categories in stratifying low and high risk patients, while stratification among intermediate risk patients was poor. Overall, agreement between FRS and US (weighted k = 0.33), CACS and US (weighted k = 0.39), and FRS and CACS (weighted k = 0.42) risk categories was fair to moderate.

Conclusion: There is a moderate agreement between non-invasive carotid vascular and coronary calcium imaging in assessment of atherosclerosis burden in patients with IRDs. The results of the study highlight potential added value of using CACS and TPA in combination with traditional risk scores to improve CV risk stratification.


Table1

Table 1. Baseline characteristics of the study population -N = 139-


Table2

Table 2. Framingham Risk Score categories versus Imaging-based risk groups


Table3

Table 3. Carotid US versus CACS-based risk categories


Disclosure: K. Colaco, None; E. Nguyen, None; S. Akhtari, None; P. Harvey, None; L. Eder, Abbvie, 2, 5, 8, Celgene, 5, Janssen, 5, Lily, 2, 5, Novartis, 2, 5, Pfizer, 2, 8, UCB, 2.

To cite this abstract in AMA style:

Colaco K, Nguyen E, Akhtari S, Harvey P, Eder L. Comparison of Carotid Ultrasound and Coronary Artery Calcium Score in Cardiovascular Risk Stratification of Patients with Inflammatory Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/comparison-of-carotid-ultrasound-and-coronary-artery-calcium-score-in-cardiovascular-risk-stratification-of-patients-with-inflammatory-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-carotid-ultrasound-and-coronary-artery-calcium-score-in-cardiovascular-risk-stratification-of-patients-with-inflammatory-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology